Recent literature data indicates abnormal levels of CacyBP/SIP in various types of cancer such as gastric cancer, breast cancer, pancreatic cancer, colorectal cancer and brain cancer (16–18). This evidence concerns the gene CACYBP and familial pancreatic carcinoma.